The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C.

Tarek Hassanein; Graham Cooksley; Mark Sulkowski; Coleman Smith; George Marinos; Ming-Yang Lai; Giuseppe Pastore; Rafael Trejo-Estrada; Ana Horta E Vale; Neil Wintfeld

doi:10.1016/j.jhep.2003.12.014

The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C.

Identifier:nobleid.org/w1/20260515/FD185F60

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FD185F60.svg?ark=w1%2F20260515%2FFD185F60)](https://nobleid.org/work/w1/20260515/FD185F60)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C.

Identifier:nobleid.org/w1/20260515/FD185F60

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/FD185F60.svg?ark=w1%2F20260515%2FFD185F60)](https://nobleid.org/work/w1/20260515/FD185F60)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work